The novel therapy of the medication represents a major breakthrough in the management of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide242528.thechapblog.com/40801480/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment